Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2006. Start Trial.
Date Value
June 30, 2026 -1.582M
March 31, 2026 -13.02M
December 31, 2025 5.717M
September 30, 2025 3.149M
June 30, 2025 3.375M
March 31, 2025 -16.65M
December 31, 2024 6.777M
September 30, 2024 -25.22M
June 30, 2024 -47.29M
March 31, 2024 -72.06M
December 31, 2023 -53.22M
September 30, 2023 -38.67M
June 30, 2023 -38.44M
March 31, 2023 -35.14M
December 31, 2022 -23.23M
September 30, 2022 -30.33M
June 30, 2022 -41.75M
March 31, 2022 -38.11M
December 31, 2021 -34.45M
September 30, 2021 -36.38M
June 30, 2021 -37.33M
March 31, 2021 -33.81M
December 31, 2020 -17.75M
September 30, 2020 -15.43M
June 30, 2020 -17.45M
Date Value
March 31, 2020 -19.68M
December 31, 2019 -11.66M
September 30, 2019 -16.13M
June 30, 2019 -9.347M
March 31, 2019 -9.012M
December 31, 2018 -12.70M
September 30, 2018 -8.719M
June 30, 2018 -5.388M
March 31, 2018 -5.71M
December 31, 2017 -1.026M
September 30, 2017 -3.476M
June 30, 2017 -3.795M
March 31, 2017 -8.028M
December 31, 2016 -11.44M
September 30, 2016 -11.95M
June 30, 2016 4.757M
March 31, 2016 -2.576M
December 31, 2015 -0.051M
September 30, 2015 -0.414M
June 30, 2015 0.727M
March 31, 2015 -6.785M
December 31, 2014 -5.537M
September 30, 2014 1.89M
June 30, 2014 -27.50M
March 31, 2014 -0.425M

Free Cash Flow Definition

Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
Artivion, Inc. -12.01M
Glaukos Corp. 12.08M
TransMedics Group, Inc. 10.22M
Abbott Laboratories 1.991B
AngioDynamics, Inc. -18.48M